Application of mode-of-action considerations in human cancer risk assessment

Toxicology Letters

Volumn 180, Issue 2, 2008, Pages 75-80

  Williams, Gary M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Bioindicator; Cancer risk assessment; DNA reactive carcinogen; Epigenetic carcinogen; Insignificant daily intake; Toxicologically

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALKENE; ALPHA 2U GLOBULIN; AROMATIC AMINE; BENZIDINE; BIOLOGICAL MARKER; BUTYLATED HYDROXYANISOLE; CARCINOGEN; CYTOTOXIN; DIETHYLNITROSAMINE; DNA; FOOD ADDITIVE; FORMALDEHYDE; IMMUNOMODULATING AGENT; LIMONENE; MYCOTOXIN; N (2 FLUORENYL)ACETAMIDE; NITROSAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENOBARBITAL; POLYCYCLIC AROMATIC HYDROCARBON; SACCHARIN; VINYL CHLORIDE;

ADVERSE OUTCOME; ARTICLE; CANCER RISK; CARCINOGENICITY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DRUG SURVEILLANCE PROGRAM; ELECTROPHILIC STRESS; EPIGENETICS; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; GENE MUTATION; GENOTOXICITY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PUBLIC HEALTH; QUALITY CONTROL; RISK ASSESSMENT; TARGET CELL; WORLD HEALTH ORGANIZATION;

ANIMALS; CARCINOGENS; DNA; DNA DAMAGE; HUMANS; NEOPLASMS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT;

EID: 48649110206     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.05.021     Document Type: Article

References (79)

1. Ames B.N. Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 2281-2285
2. Barlow S., Renwick A.G., Kleiner J., Bridges J.W., Busk L., Dybing E., Edler L., Eisenbrand G., Fink-Gremmels J., Knaap A., Kroes R., Liem D., Muller D.J., Page S., Rolland V., Schlatter J., Tritscher A., Tueting W., and Wurtzen G. Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem.Toxicol. 44 (2006) 1636-1650
3. Calabrese E.J., and Baldwin L.A. Can the concept of hormesis be generalized to carcinogenesis?. Regul. Toxicol. Pharmacol. 28 (1998) 230-241
4. 32P-postlabeling for tamoxifen-DNA adducts in the human endometrium. Carcinogenesis 20 (1999) 339-342
5. Cohen S.M., and Ellwein L.B. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the EDO1 study. Toxicol. Appl. Pharmacol. 104 (1990) 79-93
6. Cohen S.M., Meek M.E., Klaunig J.E., Patton D.E., and Fenner-Crisp P.A. The human relevance of information on carcinogenic modes of action: overview. Crit. Rev. Toxicol. 33 6 (2003) 581-589
7. Doak S.H., Jenkins G.J.S., Johnson G.E., Quick E., Parry E.M., and Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67 8 (2007) 3904-3911
8. Dybing E., Doe J., Groten J., Kleiner J., Renwick A.G., Schlatter J., Steinberg P., Tritscher A., Walker R., and Younes M. Hazard characterization of chemicals in food and diet. Dose response, mechanisms and extrapolation issues. Food Chem. Toxicol. 40 (2002) 237-2-82
9. Ehrenberg, L., Brookes, P., Druckrey, H., Lagerlof, B., Litwin, J. Williams, G. 1973. The relation of cancer induction and genetic damage. In: Evaluation of Genetic Risks of Environmental Chemicals, Ed. C. Ramel, University of Stockholm, Stockholm, Ambio Special Report No. 3, pp. 15-16.
10. European Food Safety Authority, 2005. Opinion of the Scientific Committee on a request from EFSA related to a harmonized approach for risk assessment of substances which are both genotoxic and carcinogenic. (Request No EFSA-Q-2004-020). Adopted on 18 October 2005. Available at: http://efsa.europa.eu./science/sc_committee/sc_opinions1201/sc_op_ej282_gentox_en3.pdf.
11. European Food Safety Authority (EFSA), 2006. EFA Meeting Summary Report. EFSA/WHO International Conference with Support of ILSI Europe on Risk Assessment of Compounds that are both Genotoxic and Carcinogenic, European Food Safety Authority, Parma, Italy.
12. Enzmann H., Zerban H., Kopp-Schneider A., Löser A., and Bannasch P. Effects of low doses of N-nitrosomorpholine on the development of early states of hepatocarcinogenesis. Carcinogenesis 16 (1995) 1418-1513
13. Farmer J.H., Kodell R.L., Greenman D.L., and Shaw G.W. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J. Environ. Pathol. Toxicol. 3 (1980) 55-68
14. Fukushima S. Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: relevance to risk assessment. Cancer Lett. 143 (1999) 157-159
15. Fukushima S., Wanibuchi H., Morimura K., Wei M., Nakae D., Konishi Y., Tsuda H., Uehara N., Imaida K., Shirai T., Tatematsu M., Tsukamoto T., Hirose M., Furukawa F., Wakabayashi K., and Totsuka Y. Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidaz[4,5f]quinoxaline or N-nitrosodiethylamine. Jpn. J. Cancer Res. 93 (2002) 1076-1082
16. Fukushima S., Kinoshita A., Puatanachokchai R., Kushida M., Wanibuchi H., and Morimura K. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. Carcinogenesis 26 (2005) 1835-1845
17. Gold L.S., Sawyer C.B., Magaw R., Backman G.M., de Veciana M., Levinson R., Hooper N.K., Havender W.R., Bernstein L., Peto R., Pike M.C., and Ames B.N. A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect. 58 (1984) 9-319
18. Hengstler J.G., Bogdanffy M.S., Bolt H.M., and Oesch F. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 485-520
19. Hino O., and Kitagawa T. Existence of a practical threshold dose for the haptocarcinogen 3′-methyl-4-(dimethylamino)azobenzene in rat liver. Gann 72 (1981) 637-638
20. International Agency for Research on Cancer, 1996. IARC monographs on the evaluation of carcinogenic risks to humans: some pharmaceutical drugs, 'Tamoxifen', IARC, Lyon, vol. 66, pp. 253-365.
21. International Agency for Research on Cancer, 2003. Predictive value of rodent forestomach and gastric neuroendocrine tumours in evaluating carcinogenic risks to humans. 'Summary Report', IARC, Lyon, Technical publication 39, pp. 7-14.
22. International Expert Panel on Carcinogen Risk Assessment, 1996. The use of mechanistic data in the risk assessments of ten chemicals: an introduction to the chemical-specific reviews. Pharmacol. Ther. 71 (Special Issue):1-5.
23. Jeffrey, A.M. and Williams, G.M., 2005. Risk assessment of DNA-reactive carcinogens in food. Proceedings 10th International Congress of Toxicology. Toxicology and Applied Pharmacology, 207; s628-s635.
24. Joint FAO/WHO Expert Committee on Food Additives (2005). JECFA Sixty-fourth meting, Rome, 8-17 February 2005. Summary and Conclusions. FAO/WHO. Available at ftp://ftp.fao.org/es/en/jecfa/jecfa64_summary.pdf.
25. Kirsch-Volders M., Aardema M., and Elhajouji A. Concepts of threshold in mutagenesis and carcinogenesis. Mutat. Res. 464 (2000) 3-11
26. Klaunig J.E., Kamendulis L.M., and Xu Y. Epigenetic mechanisms of chemical carcinogenesis. Human Exp. Toxicol. 19 (2000) 543-555
27. Kroes R., and Kozianowski G. Threshold of toxicological concern (TTC) in food safety assessment. Toxicol. Lett. 127 (2002) 43-46
28. Kroes R., Williams G.M., and Weisburger J.H. Early appearance of serum alpha-fetoprotein during hepatocarcinogenesis as a function of age of rats and extent of treatment with 3′-methyl-4-dimethylaminoazobenzene. Cancer Res. 32 (1972) 1526-1532
29. Kroes R., Williams G.M., and Weisburger J.H. On the precocious induction of alpha-foetoprotein by several hepatocarcinogens, including aflatoxin B1 in rats. In: Doll R., and Vodopija I. (Eds). Host Environment Interactions in the Etiology of Cancer in Man. IARC Scientific Publication, No. 7 (1973), International Agency for Research on Cancer, Lyon 307-309
30. Kroes R., Galli C., Munro I., Schliter B., Tran L.-A., Walker R., and Würtzen G. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food Chem. Toxicol. 38 (2000) 255-312
31. Kroes R., Schaefer E.J., Squire R.A., and Williams G.M. A Review of the Safety of DHA45-oil. Food Chem. Toxicol. 41 (2003) 1433-1446
32. Kroes R., Renwick A.G., Cheeseman M., Kleiner J., Mangelsdorf I., Piersma A., Schilter B., Schlatter J., van Schothorst F., Vos J.G., and Würtzen G. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 42 (2004) 65-83
33. Lijinsky W., Kovatch R.M., Riggs C.W., and Walters P.T. Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats. Cancer Res. 48 (1988) 2089-2095
34. Lobenhofer E.K., Cui X., Bennett L., Cable P.L., Merrick B.A., Churchill G.A., and Afshari C.A. Exploration of low-dose estrogen effects: identification of No Observed Transcriptional Effect Level (NOTEL). Toxicol. Pathol. 32 (2004) 482-492
35. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51 (1991) 3075-3079
36. Maekawa A., Onodera H., Matsushima Y., Nagaoka T., Todate A., Shibutani M., Kodama Y., and Hayashi Y. Dose-response carcinogenicity in rats on low-dose levels of N-ethyl-N-nitosourethane. Jpn. J. Cancer Res. 80 (1989) 632-636
37. Magnuson B.A., Burdock G.A., Doull J., Kroes R.M., Marsh G.M., Pariza M.W., Spencer P.S., Waddell W.J., Walker R., and Williams G.M. Aspartame: a safety evaluation based on current use levels, regulations, toxicological and epidemiological studies. Crit. Rev. Toxicol. 37 (2007) 627-727
38. Martin E.A., Brown K., Gaskell M., Al-Azzawi F., Garner R.C., Boocock D.J., Mattock E., Pring D.W., Dingley K., Turteltaub K.W., Smith L.L., and White I.N.H. Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry. Cancer Res. 63 (2003) 8461-8465
39. Meek M.E., Bucher J.R., Cohen S.M., DeMarco V., Hill R.N., Lehman-McKeeman L.D., Longfellow D.G., Pastorr T., Seed J., and Patton D.E. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33 (2003) 591-654
40. Miller E.C., and Miller J.A. Milestones in chemical carcinogenesis. Sem. Oncol. 6 (1979) 445-460
41. Munro I.C., Ford R.A., Kennepohl E., and Sprenger J.G. Correlation of structural class with no-observed -effect levels: a proposal for establishing a threshold of concern. Food Chem. Toxicol. 34 (1996) 829-867
42. Munro I.C., Williams G.M., Heymann H.O., and Kroes R. Tooth whitening products and risk of oral cancer. Food Chem. Toxicol. 44 (2006) 301-315
43. National Research Council, 1994. Science and Judgement in Risk Assessment, Washington, D.C.: National Academy Press.
44. National Research Council, 2006. Health risks from dioxin and related compounds, Evaluation of the EPA Reassessment, Washington DC.: National Academy Press.
45. Nestmann E.R., Bryant D.W., Carr C.J., Fennell T.T., Gallagher J.E., Gorelick N.J., Swenberg J.A., and Williams G.M. Toxicological significance of DNA adducts. Report of an expert panel. Regul. Toxicol. Pharma. 24 (1996) 9-18
46. Peto R., Gray R., Brantom P., and Grasso P. Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine; a detailed dose-response study. Cancer Res. 51 (1991) 6415-6451
47. Peto R., Gray R., Brantom P., and Grasso P. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res. 51 (1991) 6452-6469
48. Rice J.M. On the application of data on mode of action to carcinogenic risk assessment. Toxicol. Sci. 78 (2004) 175-177
49. Roberts R.A., Crump K.S., Lutz W.K., Wiegand H.-J., Williams G.M., Harrison P.T.C., and Purchase I.F.H. Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation. Arch. Toxicol. 75 (2001) 507-512
50. Root M., Lanage T., and Campbell T.C. Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver. Chem. Biol. Interact. 106 (1997) 213-227
51. Rulis A.M. De minimis and the threshold of regulation. In: Felix C.W. (Ed). Food Protection Technology (1986), Chelsea/Lewis, Michigan 29-37
52. Sander, M., Cadet, J., Casciano, D.A., Galloway, S.M., Marnett, L.J., Novak, R.F., Pettit, S.D., Preston, R.J., Skare, J., Williams, G.M., Van Houten, B. Gollapudi, B.B., 2005. Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004. Toxicol. Appl. Pharmacol. 208:1-20.
53. Sanner T., Dybing E., Willems M.I., and Krosese E.D. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25. Pharmalcol. Toxicol. 88 (2001) 331-341
54. Tsuda H., Fukushima S., Wanibuchi H., Morimura K., Nakae D., Imaida K., Tatematsu M., Hirose M., Wakabayashi K., and Moore M.A. Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis; evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work. Toxicol. Pathol. 31 (2003) 80-86
55. 2u-globulin association with chemically induced renal toxicity and neoplasia in the male rat. Prepared for the Risk Assessment Forum of the US EPA, Washington DC. EPA/625/3-91/019F.
56. U.S. Environmental Protection Agency (EPA), 2005. Guidelines for carcinogen risk assessment. Risk Assessment Forum, Washington, DC. EPA/630/P-03001F. Available from: http://www.epa.gov/ttn/atw/cancer_guidelines_final_3-25-05.pdf.
57. Vogelstein B., and Kinzler K.W. The multistep nature of cancer. Trends Genet. 9 (1993) 138-141
58. Waddell W.J., Fukushima S., and Williams G.M. Concordance of thresholds for carcinogenicity of nitrosodiethylamine. Arch. Toxicol. 80 (2006) 305-309
59. Weisburger J.H., and Williams G.M. Carcinogen testing: current problems and new approaches. Science 214 (1981) 401-407
60. Weisburger J.H., and Williams G.M. Causes of cancer. In: Murphy G.P., Lawrence Jr. W., and Lenhard Jr. R.E. (Eds). American Cancer Society Textbook of Clinical Oncology (1995), American Cancer Society, Inc, Atlanta, GA 10-39
61. Whysner J., and Williams G.M. Butylated hydroxyanisole mechanistic data and risk assessment: Conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 71 (1996) 137-152
62. Whysner J., Ross P.M., and Williams G.M. Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharm. Ther. 71 (1996) 153-192
63. Williams G.M. Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Annals New York Academy of Sciences 349 (1980) 273-282
64. Williams G.M. Epigenetic mechanisms of liver tumor promotion. In: Stevenson D.E., McClain R.M., Popp J.A., Slaga T.J., Ward J.M., and Pitot H.C. (Eds). Mouse Liver Carcinogenesis (1990), Alan R. Liss, Inc, New York 121-145
65. Williams, G.M., 1990b. Screening procedures for evaluating the potential carcinogenicity of food packaging chemicals. Regul. Toxicol. Pharmacol., 12:30-40, 1990.
66. Williams G.M. DNA reactive and epigenetic carcinogens. Exp. Toxicol. Pathol. 44 (1992) 457-464
67. Williams G.M. Mechanistic considerations in cancer risk assessment. Inhal. Toxicol. 11 (1999) 549-554
68. Williams G.M. Mechanisms of chemical carcinogenesis and application to human cancer risk assessment. Toxicology 166 (2001) 3-10
69. Williams G.M., and Iatropoulos M.J. Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol. Pathol. 30 (2002) 41-53
70. Williams G.M., and Whysner J. Mechansitic considerations in risk assessment for epigenetic tumor-promoting arcinogens. In: McClain R.M., Slaga T.J., LeBoeuf R., and Pitot H. (Eds). Growth Factors and Tumor Promotion: Implications for Risk Assessment (1995), John Wiley and Sons, Inc., New York 369-383
71. Williams G.M., and Whysner J. Epigenetic carcinogens: evaluation and risk assessment. Exp. Toxicol. Pathol. 48 (1996) 189-195
72. Williams G.M., Stromberg K., and Kroes R. Cytochemical and ultrastructural alterations associated with confluent growth in cell cultures of epithelial-like cells from rat liver. Lab. Invest. 29 (1973) 293-303
73. Williams G.M., Reiss B., and Weisburger J.H. A comparison of the animal and human carcinogenicity of several environmental, occupation and therapeutic chemicals. In: Flamm G., and Lorentzen R. (Eds). Mechanisms and Toxicity of Chemical Carcinogens and Mutagens. Advances in Environmental Toxicology, Vol IX (1985), Princeton Scientific Publishers, Princeton, NJ 207-248
74. Williams G.M., Karbe E., Fenner-Crisp P., Iatropoulos M.J., and Weisburger J.H. Risk assessment of carcinogens in food with special consideration of non-genotoxic carcinogens: scientific arguments for use of risk assessment and for changing the Delaney Clause specifically. Exp. Toxicol. Pathol. 48 (1996) 119-125
75. Williams G.M., Iatropoulos M.J., and Jeffrey A.M. Mechanistic basis for non-linearity and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol. Pathol. 28 (2000) 388-395
76. Williams G.M., Kroes R., and Munro I.C. Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans. Regul. Pharmacol. Toxicol. 31 (2000) 117-165
77. Williams G.M., Iatropoulos M.J., and Jeffrey A.M. Thresholds for DNA-reactive (genotoxic) organic carcinogens. J. Toxicol. Pathol. 18 (2005) 69-77
78. Williams G.M., Iatropoulos M.J., and Enzmann H.G. In: Wallace Hayes A. (Ed). Principles of testing for carcinogenic activity Principles and Methods of Toxicology (2008), Taylor and Francis, Philadelphia, PA 1271-1322
79. World Health Organization (1999) Principles for the assessment of risk to human health from exposure to chemicals. Environmental Health Criteria No. 210, WHO, Geneva.